IP Library Granted Patent US 11,819,453
Granted Patent B2
US 11,819,453 · App. 16/852,123 · Granted Nov 21, 2023

Micro-droplet delivery device and methods

Inventor: Yehuda Ivri (Newport Coast, CA)
Assignee: Novartis AG
A61F9/0008F04B43/046
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,819,453
App. No.
16/852,123
Granted
Nov 21, 2023
Kind
B2
Abstract

Micro-droplet delivery devices and methods are described where the device may comprise a piezoelectric actuator having a piezoelectric chip that is operatively coupled to a drug package under a preloading force. The actuator is configured to generate an acoustic pressure within the drug package to dispense droplets of an agent from an aperture, e.g., to the corneal surface of the eye. The piezoelectric actuator can be coupled or decoupled from the drug package.

Claims (19)

1. Apparatus for emitting an ophthalmic fluid, the apparatus comprising:

a drug package having (a) a reservoir configured to contain the fluid, (b) a cavity to accommodate a volume of the fluid from the reservoir, (c) an aperture through which the fluid in the cavity can be ejected, and (d) a pathway between the reservoir and the cavity to direct the fluid from the reservoir into the cavity, the pathway having a cross-sectional area smaller than that of the cavity; and

an actuator removably coupled to the drug package and designed to deliver a series of successive oscillations to the cavity such that the fluid within the cavity is ejected through the aperture as a result of the successive oscillations.

2. The apparatus of claim 1 , wherein the actuator is configured to have a displacement of 1-5 microns.

3. The apparatus of claim 1 , wherein the aperture has a diameter of 80-120 microns.

4. The apparatus of claim 1 , wherein the actuator is configured to eject the fluid through the aperture at a frequency of 10 Hz-30 KHz.

5. A device for dispensing a fluid at an eye of a patient, the device comprising:

a drug package having (a) a reservoir configured to contain the fluid, (b) a cavity to accommodate a volume of the fluid from the reservoir and having an aperture through which the fluid in the cavity can be ejected, and (c) a fluid pathway between the reservoir and the cavity to direct the fluid from the reservoir into the cavity, the pathway having a cross-sectional area smaller than that of the cavity;

an actuator designed to deliver a series of oscillations to the cavity such that the fluid from the cavity is ejected through the aperture; and

a surface disposed on the cavity designed to lockingly engage with a complementary surface disposed on the actuator, thereby restricting lateral movement of the drug package.

6. The device of claim 5 , wherein the actuator oscillates at a frequency of 10 Hz-30 KHz.

7. The device of claim 5 , wherein the drug package further comprises:

a venting port to permit air to enter the reservoir as the fluid is dispensed, thereby preventing a vacuum.

8. The device of claim 5 , wherein the device further comprises:

a spring member disposed proximate to the actuator, where the spring member provides a clamping force on the drug package, further restricting disengagement from the actuator while permitting disengagement from the actuator with sufficient force.

9. The device of claim 5 , wherein the surface disposed on the cavity is a concave surface and the complementary surface disposed on the actuator is a pin designed to lockingly engage with the concave surface to restrict lateral movement of the drug package.

10. Apparatus for emitting an ophthalmic fluid, the apparatus comprising:

a drug package having (a) a reservoir configured to contain the fluid, (b) a cavity to accommodate a volume of the fluid from the reservoir, (c) an aperture through which the fluid in the cavity can be ejected, and (d) a pathway between the reservoir and the cavity to direct the fluid from the reservoir into the cavity; and

an actuator removably coupled to the drug package and designed to deliver a series of successive oscillations to the cavity such that i) the fluid within the cavity is ejected through the aperture as a result of the successive oscillations and ii) during actuation, a cross-sectional area of the cavity is not smaller than a cross-sectional area of the pathway.

Assignments (8)
ASSIGNMENT OF SECURITY INTEREST IN PATENTS PREVIOUSLY RECORDED AT REEL/FRAME (066694/0131) Recorded Aug 14, 2025
From: CITIBANK, N.A., AS RESIGNING AGENT
To: JPMORGAN CHASE BANK, N.A., AS SUCCESSOR AGENT
Reel/Frame 072460/0655 →
PATENT SECURITY AGREEMENT Recorded Jul 1, 2025
From: BAUSCH & LOMB INCORPORATED; ALDEN OPTICAL LABORATORIES, INC.; BAUSCH + LOMB IRELAND LIMITED
To: CITIBANK, N.A., AS NOTES COLLATERAL AGENT
Reel/Frame 071773/0871 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Feb 29, 2024
From: BAUSCH + LOMB IRELAND LIMITED
To: CITIBANK, N.A., AS NOTES COLLATERAL AGENT
Reel/Frame 066707/0684 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Feb 27, 2024
From: BAUSCH + LOMB IRELAND LIMITED
To: CITIBANK, N.A., AS COLLATERAL AGENT
Reel/Frame 066694/0131 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 9, 2023
From: NOVARTIS AG
To: BAUSCH + LOMB IRELAND LIMITED
Reel/Frame 065531/0583 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNMENT AGREEMENT PREVIOUSLY RECORDED ON REEL 062116 FRAME 0917. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jul 10, 2023
From: KEDALION THERAPEUTICS, INC.
To: NOVARTIS AG
Reel/Frame 064237/0507 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 13, 2022
From: KEDALION THERAPEUTICS, INC.
To: NOVARTIS AG
Reel/Frame 062116/0917 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 17, 2020
From: IVRI, YEHUDA
To: KEDALION THERAPEUTICS, INC.
Reel/Frame 052432/0674 →
Continuity (3)
Continuation 14992975 · Jan 11, 2016
Provisional Application 62125073 · Jan 12, 2015
Related Publication 20200246182A1 · Aug 6, 2020